Amit Ranjan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amit Ranjan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Rajiv Misra
Indian Institute of Technology Patna
4 shared publications - Supratik Mukhopadhyay
Louisiana State University
2 shared publications Adam Bess
Department of Environmental Sciences, Louisiana State University, Baton Rouge, Louisiana 70803, United States
1 shared publication- Adam Bess
Department of Computer Science Louisiana State University Baton Rouge Louisiana USA
1 shared publication - Aixin Hou
Louisiana State University
1 shared publication - Archit Anand
Department of Metallurgical and Materials Engineering, Indian Institute of Technology Patna, Bihta, India
1 shared publication
Latest Publications
- Open Access
- 8 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-8
Trans-ARG: Predicting Antibiotic Resistance Genes with a Transformer-Based Model and Pretrained Protein Language Model
- 8 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-8
Open AccessTrans-ARG: Predicting Antibiotic Resistance Genes with a Transformer-Based Model and Pretrained Protein Language Model
- Open Access
- 8 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-9
KG-DTA: A knowledge graph-based meta-path learning framework to predict drug-target binding affinity
- 8 October 2024
- Published by Association for Computing Machinery (ACM)
- p. 1-9
Open AccessKG-DTA: A knowledge graph-based meta-path learning framework to predict drug-target binding affinity
- Open Access
- 18 June 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (13) , 4980-4990
MDF-DTA: A Multi-Dimensional Fusion Approach for Drug-Target Binding Affinity Prediction
Drug-target affinity (DTA) prediction is an important task in the early stages of drug discovery. Traditional biological approaches are time-consuming, effort-consuming, and resource-consuming due to the large size of genomic and chemical spaces. Computational approaches using machine learning have emerged to narrow down the drug candidate search space. However, most of these prediction models focus on single feature encoding of drugs and targets, ignoring the importance of integrating different dimensions of these features. We propose a deep learning-based approach called Multi-Dimensional Fusion for Drug Target Affinity Prediction (MDF-DTA) incorporating different dimensional features. Our model fuses 1D, 2D, and 3D representations obtained from different pretrained models for both drugs and targets. We evaluated MDF-DTA on two standard benchmark data sets: DAVIS and KIBA. Experimental results show that MDF-DTA outperforms many state-of-the-art techniques in the DTA task across both data sets. Through ablation studies and performance evaluation metrics, we evaluate the importance of individual representations and the impact of each representation on MDF-DTA.
- 18 June 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (13) , 4980-4990
Open AccessMDF-DTA: A Multi-Dimensional Fusion Approach for Drug-Target Binding Affinity Prediction
Drug-target affinity (DTA) prediction is an important task in the early stages of drug discovery. Traditional biological approaches are time-consuming, effort-consuming, and resource-consuming due to the large size of genomic and chemical spaces. Computational approaches using machine learning have emerged to narrow down the drug candidate search space. However, most of these prediction models focus on single feature encoding of drugs and targets, ignoring the importance of integrating different dimensions of these features. We propose a deep learning-based approach called Multi-Dimensional Fusion for Drug Target Affinity Prediction (MDF-DTA) incorporating different dimensional features. Our model fuses 1D, 2D, and 3D representations obtained from different pretrained models for both drugs and targets. We evaluated MDF-DTA on two standard benchmark data sets: DAVIS and KIBA. Experimental results show that MDF-DTA outperforms many state-of-the-art techniques in the DTA task across both data sets. Through ablation studies and performance evaluation metrics, we evaluate the importance of individual representations and the impact of each representation on MDF-DTA.
- 7 June 2023
- Published by Springer Nature
- p. 401-410
Training Generative Adversarial Networks (GANs) Over Parameter Server and Worker Node Architecture
- 7 June 2023
- Published by Springer Nature
- p. 401-410
Training Generative Adversarial Networks (GANs) Over Parameter Server and Worker Node Architecture
- 6 January 2023
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 12 (1) , 1-13
Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph
AI-driven approaches are widely used in drug discovery, where candidate molecules are generated and tested on a target protein for binding affinity prediction. However, generating new compounds with desirable molecular properties such as Quantitative Estimate of Drug-likeness (QED) and Dopamine Receptor D2 activity (DRD2) while adhering to distinct chemical laws is challenging. To address these challenges, we proposed a graph-based deep learning framework to generate potential therapeutic drugs targeting the SARS-CoV-2 protein. Our proposed framework consists of two modules: a novel reinforcement learning (RL)-based graph generative module with knowledge graph (KG) and a graph early fusion approach (GEFA) for binding affinity prediction. The first module uses a gated graph neural network (GGNN) model under the RL environment for generating novel molecular compounds with desired properties and a custom-made KG for molecule screening. The second module uses GEFA to predict binding affinity scores between the generated compounds and target proteins. Experiments show how fine-tuning the GGNN model under the RL environment enhances the molecules with desired properties to generate \(100\%\) valid and \(100\%\) unique compounds using different scoring functions. Additionally, KG-based screening reduces the search space of generated candidate molecules by \(96.64\%\) while retaining \(95.38\%\) of promising binding molecules against SARS-CoV-2 protein, i.e., 3C-like protease (3CLpro). We achieved a binding affinity score of 8.185 from the top rank of generated compound. In addition, we compared top-ranked generated compounds to Indinavir on different parameters, including drug-likeness and medicinal chemistry, for qualitative analysis from a drug development perspective.- 6 January 2023
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 12 (1) , 1-13
Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph
AI-driven approaches are widely used in drug discovery, where candidate molecules are generated and tested on a target protein for binding affinity prediction. However, generating new compounds with desirable molecular properties such as Quantitative Estimate of Drug-likeness (QED) and Dopamine Receptor D2 activity (DRD2) while adhering to distinct chemical laws is challenging. To address these challenges, we proposed a graph-based deep learning framework to generate potential therapeutic drugs targeting the SARS-CoV-2 protein. Our proposed framework consists of two modules: a novel reinforcement learning (RL)-based graph generative module with knowledge graph (KG) and a graph early fusion approach (GEFA) for binding affinity prediction. The first module uses a gated graph neural network (GGNN) model under the RL environment for generating novel molecular compounds with desired properties and a custom-made KG for molecule screening. The second module uses GEFA to predict binding affinity scores between the generated compounds and target proteins. Experiments show how fine-tuning the GGNN model under the RL environment enhances the molecules with desired properties to generate \(100\%\) valid and \(100\%\) unique compounds using different scoring functions. Additionally, KG-based screening reduces the search space of generated candidate molecules by \(96.64\%\) while retaining \(95.38\%\) of promising binding molecules against SARS-CoV-2 protein, i.e., 3C-like protease (3CLpro). We achieved a binding affinity score of 8.185 from the top rank of generated compound. In addition, we compared top-ranked generated compounds to Indinavir on different parameters, including drug-likeness and medicinal chemistry, for qualitative analysis from a drug development perspective.- 1 January 2022
- Published by Springer Nature
- p. 17-28
Transfer Learning Based Approach for Pneumonia Detection Using Customized VGG16 Deep Learning Model
- 1 January 2022
- Published by Springer Nature
- p. 17-28
Transfer Learning Based Approach for Pneumonia Detection Using Customized VGG16 Deep Learning Model
- 18 December 2021
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 11 (1) , 1-11
Generating novel molecule for target protein (SARS-CoV-2) using drug–target interaction based on graph neural network
The transmittable spread of viral coronavirus (SARS-CoV-2) has resulted in a significant rise in global mortality. Due to lack of effective treatment, our aim is to generate a highly potent active molecule that can bind with the protein structure of SARS-CoV-2. Different machine learning and deep learning approaches have been proposed for molecule generation; however, most of these approaches represent the drug molecule and protein structure in 1D sequence, ignoring the fact that molecules are by nature in 3D structure, and because of this many critical properties are lost. In this work, a framework is proposed that takes account of both tertiary and sequential representations of molecules and proteins using Gated Graph Neural Network (GGNN), Knowledge graph, and Early Fusion approach. The generated molecules from GGNN are screened using Knowledge Graph to reduce the search space by discarding the non-binding molecules before being fed into the Early Fusion model. Further, the binding affinity score of the generated molecule is predicted using the early fusion approach. Experimental result shows that our framework generates valid and unique molecules with high accuracy while preserving the chemical properties. The use of a knowledge graph claims that the entire generated dataset of molecules was reduced by roughly 96% while retaining more than 85% of good binding desirable molecules and the rejection of more than 99% of fruitless molecules. Additionally, the framework was tested with two of the SARS-CoV-2 viral proteins: RNA-dependent-RNA polymerase (RdRp) and 3C-like protease (3CLpro).
- 18 December 2021
- Published by Springer Nature in Network Modeling Analysis in Health Informatics and Bioinformatics
- Vol. 11 (1) , 1-11
Generating novel molecule for target protein (SARS-CoV-2) using drug–target interaction based on graph neural network
The transmittable spread of viral coronavirus (SARS-CoV-2) has resulted in a significant rise in global mortality. Due to lack of effective treatment, our aim is to generate a highly potent active molecule that can bind with the protein structure of SARS-CoV-2. Different machine learning and deep learning approaches have been proposed for molecule generation; however, most of these approaches represent the drug molecule and protein structure in 1D sequence, ignoring the fact that molecules are by nature in 3D structure, and because of this many critical properties are lost. In this work, a framework is proposed that takes account of both tertiary and sequential representations of molecules and proteins using Gated Graph Neural Network (GGNN), Knowledge graph, and Early Fusion approach. The generated molecules from GGNN are screened using Knowledge Graph to reduce the search space by discarding the non-binding molecules before being fed into the Early Fusion model. Further, the binding affinity score of the generated molecule is predicted using the early fusion approach. Experimental result shows that our framework generates valid and unique molecules with high accuracy while preserving the chemical properties. The use of a knowledge graph claims that the entire generated dataset of molecules was reduced by roughly 96% while retaining more than 85% of good binding desirable molecules and the rejection of more than 99% of fruitless molecules. Additionally, the framework was tested with two of the SARS-CoV-2 viral proteins: RNA-dependent-RNA polymerase (RdRp) and 3C-like protease (3CLpro).
- 6 November 2021
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 35 (3) , 449-457
GAN for synthesizing CT from T2-weighted MRI data towards MR-guided radiation treatment
Objective In medical domain, cross-modality image synthesis suffers from multiple issues , such as context-misalignment, image distortion, image blurriness, and loss of details. The fundamental objective behind this study is to address these issues in estimating synthetic Computed tomography (sCT) scans from T2-weighted Magnetic Resonance Imaging (MRI) scans to achieve MRI-guided Radiation Treatment (RT). Materials and methods We proposed a conditional generative adversarial network (cGAN) with multiple residual blocks to estimate sCT from T2-weighted MRI scans using 367 paired brain MR-CT images dataset. Few state-of-the-art deep learning models were implemented to generate sCT including Pix2Pix model, U-Net model, autoencoder model and their results were compared, respectively. Results Results with paired MR-CT image dataset demonstrate that the proposed model with nine residual blocks in generator architecture results in the smallest mean absolute error (MAE) value of \(0.030 \pm 0.017\), and mean squared error (MSE) value of \(0.010 \pm 0.011\), and produces the largest Pearson correlation coefficient (PCC) value of \(0.954 \pm 0.041\), SSIM value of \(0.823 \pm 0.063\) and peak signal-to-noise ratio (PSNR) value of \(21.422 \pm 3.964\), respectively. We qualitatively evaluated our result by visual comparisons of generated sCT to original CT of respective MRI input. Discussion The quantitative and qualitative comparison of this work demonstrates that deep learning-based cGAN model can be used to estimate sCT scan from a reference T2 weighted MRI scan. The overall accuracy of our proposed model outperforms different state-of-the-art deep learning-based models.- 6 November 2021
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 35 (3) , 449-457
GAN for synthesizing CT from T2-weighted MRI data towards MR-guided radiation treatment
Objective In medical domain, cross-modality image synthesis suffers from multiple issues , such as context-misalignment, image distortion, image blurriness, and loss of details. The fundamental objective behind this study is to address these issues in estimating synthetic Computed tomography (sCT) scans from T2-weighted Magnetic Resonance Imaging (MRI) scans to achieve MRI-guided Radiation Treatment (RT). Materials and methods We proposed a conditional generative adversarial network (cGAN) with multiple residual blocks to estimate sCT from T2-weighted MRI scans using 367 paired brain MR-CT images dataset. Few state-of-the-art deep learning models were implemented to generate sCT including Pix2Pix model, U-Net model, autoencoder model and their results were compared, respectively. Results Results with paired MR-CT image dataset demonstrate that the proposed model with nine residual blocks in generator architecture results in the smallest mean absolute error (MAE) value of \(0.030 \pm 0.017\), and mean squared error (MSE) value of \(0.010 \pm 0.011\), and produces the largest Pearson correlation coefficient (PCC) value of \(0.954 \pm 0.041\), SSIM value of \(0.823 \pm 0.063\) and peak signal-to-noise ratio (PSNR) value of \(21.422 \pm 3.964\), respectively. We qualitatively evaluated our result by visual comparisons of generated sCT to original CT of respective MRI input. Discussion The quantitative and qualitative comparison of this work demonstrates that deep learning-based cGAN model can be used to estimate sCT scan from a reference T2 weighted MRI scan. The overall accuracy of our proposed model outperforms different state-of-the-art deep learning-based models.